Probiotics: are they beneficial?

Sasha R. Fehily; Chamara Basnayake; Emily K. Wright; C. K. Yao; Jack Godsell; Peter R. Gibson; Michael A. Kamm

doi:10.1111/imj.16388

Probiotics: are they beneficial?

Sasha R. Fehily, Chamara Basnayake, Emily K. Wright, C. K. Yao, Jack Godsell, Peter R. Gibson, Michael A. Kamm

Gastroenterology

Research output: Contribution to journal › Article › Research › peer-review

4 Citations (Scopus)

Abstract

There are wide-ranging probiotic choices in Australasia. We reviewed the efficacy of probiotics for the management of gastrointestinal (GI) conditions in adults and assessed relevance to clinical practice. The benefits of probiotics were inconsistent, with a strong consensus reached for only a few of the indications. As different species/strains and combinations differ in efficacy, results cannot be extrapolated from one to another. This review endorses specific probiotics for limited indications. Efficacy of most marketed probiotic formulations remains unstudied and unproven, warranting further research.

Original language	English
Pages (from-to)	861-870
Number of pages	10
Journal	Internal Medicine Journal
Volume	54
Issue number	6
DOIs	https://doi.org/10.1111/imj.16388
Publication status	Published - Jun 2024

Keywords

gastrointestinal diseases
microbiota
probiotics

Access to Document

10.1111/imj.16388

Cite this

@article{d7b090dbd9f941ee86dcec89369eac14,

title = "Probiotics: are they beneficial?",

abstract = "There are wide-ranging probiotic choices in Australasia. We reviewed the efficacy of probiotics for the management of gastrointestinal (GI) conditions in adults and assessed relevance to clinical practice. The benefits of probiotics were inconsistent, with a strong consensus reached for only a few of the indications. As different species/strains and combinations differ in efficacy, results cannot be extrapolated from one to another. This review endorses specific probiotics for limited indications. Efficacy of most marketed probiotic formulations remains unstudied and unproven, warranting further research.",

keywords = "gastrointestinal diseases, microbiota, probiotics",

author = "Fehily, \{Sasha R.\} and Chamara Basnayake and Wright, \{Emily K.\} and Yao, \{C. K.\} and Jack Godsell and Gibson, \{Peter R.\} and Kamm, \{Michael A.\}",

note = "Funding Information: Funding: S. R. Fehily, E. K. Wright and M. A. Kamm are supported by the Australian National Health and Medical Research Council (NHMRC) and the Leona M. and Harry B. Helmsley Charitable Trust. Publisher Copyright: {\textcopyright} 2024 Royal Australasian College of Physicians.",

year = "2024",

month = jun,

doi = "10.1111/imj.16388",

language = "English",

volume = "54",

pages = "861--870",

journal = "Internal Medicine Journal",

issn = "1444-0903",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Probiotics

T2 - are they beneficial?

AU - Fehily, Sasha R.

AU - Basnayake, Chamara

AU - Wright, Emily K.

AU - Yao, C. K.

AU - Godsell, Jack

AU - Gibson, Peter R.

AU - Kamm, Michael A.

N1 - Funding Information: Funding: S. R. Fehily, E. K. Wright and M. A. Kamm are supported by the Australian National Health and Medical Research Council (NHMRC) and the Leona M. and Harry B. Helmsley Charitable Trust. Publisher Copyright: © 2024 Royal Australasian College of Physicians.

PY - 2024/6

Y1 - 2024/6

N2 - There are wide-ranging probiotic choices in Australasia. We reviewed the efficacy of probiotics for the management of gastrointestinal (GI) conditions in adults and assessed relevance to clinical practice. The benefits of probiotics were inconsistent, with a strong consensus reached for only a few of the indications. As different species/strains and combinations differ in efficacy, results cannot be extrapolated from one to another. This review endorses specific probiotics for limited indications. Efficacy of most marketed probiotic formulations remains unstudied and unproven, warranting further research.

AB - There are wide-ranging probiotic choices in Australasia. We reviewed the efficacy of probiotics for the management of gastrointestinal (GI) conditions in adults and assessed relevance to clinical practice. The benefits of probiotics were inconsistent, with a strong consensus reached for only a few of the indications. As different species/strains and combinations differ in efficacy, results cannot be extrapolated from one to another. This review endorses specific probiotics for limited indications. Efficacy of most marketed probiotic formulations remains unstudied and unproven, warranting further research.

KW - gastrointestinal diseases

KW - microbiota

KW - probiotics

UR - http://www.scopus.com/inward/record.url?scp=85192370795&partnerID=8YFLogxK

U2 - 10.1111/imj.16388

DO - 10.1111/imj.16388

M3 - Article

C2 - 38717051

AN - SCOPUS:85192370795

SN - 1444-0903

VL - 54

SP - 861

EP - 870

JO - Internal Medicine Journal

JF - Internal Medicine Journal

IS - 6

ER -

Probiotics: are they beneficial?

Abstract

Keywords

Access to Document

Other files and links

Cite this